The effect of Betahistine on nausea and vomiting after surgery

The effect of Betahistine on nausea and vomiting after Laparoscopic Cholecystectomy

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200902048594N1

Enrollment

Registered

2020-09-22

Start date

2020-09-05

Completion date

Unknown

Last updated

2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative nausea and vomiting. Nausea with vomiting, unspecified

Interventions

Intervention 1: Intervention group:Betahistine at a dose of 16 mg from Ecterco factory, which is given to patients 3 hours before laparoscopic cholecystectomy. Intervention 2: Control group: placebo w

Eligibility

Sex/Gender

All

Age

20 Years to 70 Years

Inclusion criteria

Inclusion criteria: All patients undergoing Laparoscopic Cholecystectomy

Exclusion criteria

Exclusion criteria: BMI more than 35 Allergy to drugs Receive anti-inflammatory medication 24 hours before surgery

Design outcomes

Primary

Measure	Time frame
Score of nausea and vomiting after Laparoscopic Cholecystectomy. Timepoint: Patients will receive medication 3 hours before cholecystectomy. Method of measurement: Questionnaire.	—

Secondary

Measure	Time frame
Patient satisfaction with nausea and vomiting control. Timepoint: The first 30 minutes and 30 minutes to 24 hours after the operation will be asked. Method of measurement: Questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Fateme Amirkhalili

Islamic Azad University

dr.amirkhalili@yahoo.com+98 23 3223 1067

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026